How to Help Your Patients Save Money on Brimonidine: A Provider's Guide to Savings Programs

Why Prescription Cost Matters for Brimonidine Adherence

Glaucoma treatment only works if patients actually use their drops. Yet studies consistently show that medication cost is one of the top reasons patients with glaucoma skip doses, stretch refills, or abandon treatment entirely. For a disease with no symptoms until irreversible vision loss occurs, non-adherence due to cost is a preventable tragedy.

Brimonidine is one of the more affordable glaucoma medications in its generic form — but patients don't always know that. And when they're prescribed brand-name Alphagan P, Combigan, or Simbrinza, the sticker shock at the pharmacy counter can derail even the most motivated patient.

This guide gives you the tools to have proactive cost conversations and connect your patients with the right savings programs.

What Your Patients Are Actually Paying

Understanding the price landscape helps you make informed prescribing decisions:

Generic Brimonidine 0.2% (Ophthalmic Solution)

• Cash price: $8–$40 for a 5 mL bottle
• With discount cards: $7–$15 (GoodRx, SingleCare, RxSaver)
• Insurance: Typically Tier 1 preferred generic — $0–$10 copay on most plans

Alphagan P (Brand Name, 0.1% or 0.15%)

• Cash price: $200–$270 per bottle
• Insurance: Often Tier 3 or requires prior authorization / step therapy
• Patient cost with insurance: $30–$75+ copay depending on plan

Combigan (Brimonidine/Timolol Combination)

• Cash price: $200+ per bottle
• Generic available: Yes — generic Brimonidine/Timolol is significantly cheaper ($25–$80)

Simbrinza (Brinzolamide/Brimonidine Combination)

• Cash price: $300+ per bottle
• No generic available as of early 2026

The takeaway: generic Brimonidine 0.2% is extremely affordable. The cost barrier primarily affects patients on brand-name products or combination agents without generic equivalents.

Manufacturer Savings Programs

AbbVie At Your Service (Alphagan P, Combigan)

• Program: Co-pay assistance card for commercially insured patients
• Savings: Up to $2,160 per calendar year
• Eligibility: Commercially insured patients. Not valid for Medicare, Medicaid, Tricare, or other government-funded programs
• How to enroll: Visit savewithays.com or call 1-800-347-4500
• What you can do: Keep brochures in your office, have staff help patients enroll before they leave, and note the program in after-visit summaries

Allergan Patient Assistance Program (AbbVie)

• Program: Free medication for eligible uninsured or underinsured patients
• Covers: Alphagan P, Combigan, and other Allergan products
• Eligibility: Patients without insurance or with inadequate coverage, meeting income requirements
• How to enroll: Applications through rxabbvie.com or submitted by the prescribing provider's office
• Provider role: You may need to complete and sign the application — consider building this into your workflow for patients who express financial hardship

Discount and Coupon Card Programs

For patients paying cash or facing high copays on generic Brimonidine, discount card programs can reduce costs significantly:

• GoodRx — Shows real-time prices at nearby pharmacies with free printable or digital coupons. Generic Brimonidine 0.2% often drops to $7–$15.
• SingleCare — Similar to GoodRx, accepted at most major chains including CVS, Walgreens, and Walmart.
• RxSaver — Compares prices across pharmacies with downloadable coupons.
• Optum Perks — Offers competitive pricing, particularly at Costco and independent pharmacies.
• BuzzRx — Free discount card with no registration required.

These programs work for anyone — insured or uninsured. For some patients, a discount card price may actually be lower than their insurance copay. Encourage patients to compare both options.

For a comprehensive list, see our patient-facing guide on how to save money on Brimonidine.

Generic Alternatives and Therapeutic Substitution

When cost is the primary barrier, consider these prescribing strategies:

Start with Generic Brimonidine 0.2%

For most patients, generic Brimonidine 0.2% is clinically appropriate and costs a fraction of brand-name alternatives. At $7–$15 with a discount card, it's one of the most affordable glaucoma medications available. Unless there's a specific clinical reason to use Alphagan P (e.g., preservative sensitivity requiring Purite), starting generic is both evidence-based and cost-effective.

Consider Concentration Adjustments

Alphagan P is available in 0.15% and 0.1% concentrations with a gentler preservative. If a patient needs the lower concentration or the Purite formulation, the manufacturer savings program can help offset the brand-name cost. However, for many patients, generic 0.2% with proper instillation technique is well-tolerated.

Therapeutic Alternatives When Brimonidine Isn't Affordable

If even generic Brimonidine is a stretch (uncommon but possible for uninsured patients on fixed incomes), consider:

• Timolol 0.5% — Generic beta-blocker eye drops, often $4–$10 for a bottle. Dosed twice daily. Avoid in patients with asthma, COPD, or bradycardia.
• Latanoprost (generic Xalatan) — Generic prostaglandin analog, $8–$20. Dosed once daily at bedtime. Strong IOP-lowering efficacy.
• Dorzolamide (generic Trusopt) — Generic carbonic anhydrase inhibitor, $10–$25. Dosed three times daily.

All of these generics are well under $25 with discount cards. For patients needing combination therapy, prescribing two separate generic drops may be far cheaper than a single brand-name combination product.

Avoid Unnecessary Brand-Name Prescribing

Writing "DAW" (dispense as written) or specifying brand-name products when generics are available adds significant cost with limited clinical benefit in most cases. Review your prescribing habits and default to generic when clinically appropriate.

Building Cost Conversations into Your Workflow

Many providers feel awkward discussing medication costs — but patients overwhelmingly want these conversations. Here's how to make them routine:

At the Point of Prescribing

• Mention the generic option proactively: "I'm prescribing Brimonidine eye drops. The generic version works well and is very affordable — usually under $15 with a discount card."
• Ask about barriers: "Do you have any concerns about filling this prescription? Cost, pharmacy access, anything like that?"
• Provide a savings resource: Hand patients a printed sheet or direct them to medfinder.com's savings guide

At Follow-Up Visits

• Check adherence with cost in mind: "Are you using your drops three times a day as prescribed? Some patients have trouble keeping up — is there anything getting in the way?"
• Reassess if cost is a factor: A patient who's stretching a bottle to last two months instead of one is undertreating their glaucoma

In Your Office Systems

• Train front desk and technician staff on available patient assistance programs
• Keep enrollment forms for AbbVie's programs accessible
• Build cost-conversation prompts into your EHR templates
• Consider posting information about Medfinder for Providers in your office to help patients find medications and pharmacies

Additional Patient Resources

Direct patients to these resources when they need extra help:

• NeedyMeds (needymeds.org) — Database of patient assistance programs, discount drug cards, and other cost-saving resources
• RxAssist (rxassist.org) — Comprehensive directory of pharmaceutical company patient assistance programs
• RxHope (rxhope.com) — Helps patients apply to manufacturer assistance programs
• Medfinder (medfinder.com) — Helps patients find medications in stock at nearby pharmacies with pricing information

Final Thoughts

The most effective glaucoma medication is the one your patient actually uses. For Brimonidine, cost is rarely an insurmountable barrier — generic versions are among the most affordable eye drops available. But patients need to know that, and they need your guidance to navigate the sometimes confusing landscape of brands, generics, and savings programs.

A 30-second cost conversation at the point of prescribing can be the difference between a compliant patient and one who silently abandons therapy. Make it part of your practice.

For more clinical resources and tools to help your patients, visit Medfinder for Providers.